Particulate-Based Single-Dose Local Immunosuppressive Regimen for Inducing Tolerogenic Dendritic Cells in Xenogeneic Islet Transplantation.
Shiva PathakSuman AcharyaShobha RegmiPrakash ShresthaZhiwei YouYoung Kyung BaeMin Hui ParkSimmyung YookJae-Ryong KimSo Young ParkDaewon JeongChul Soon YongJong Oh KimJae Hoon ChangJee-Heon JeongPublished in: Advanced healthcare materials (2020)
Recent studies emphasize on developing immune tolerance by an interim administration of various immunosuppressive drugs. In this study, a robust protocol is reported for local immunomodulation using a single-dose of FK506 microspheres and clodronate liposomes (mFK+CLO) in a xenogeneic model of islet transplantation. Surprisingly, the single-dose treatment with mFK+CLO induce tolerance to the islet xenograft. The recipient mice display tolerogenic dendritic cells (tDCs) with decreased antigen presenting ability and T cell activation capacity. Furthermore, a reduced percentage of CD4+ and CD8+ T cells and an impaired differentiation of naïve CD4+ T cells into interferon-γ producing Th1 and interleukin-17 producing Th17 cells are observed. In addition, the immunosuppressive protocol leads to the generation of Foxp3+ regulatory T cells (Tregs) which are required for the long-term graft survival. The enhanced generation of tDCs and Tregs by the single treatment of mFK+CLO cause xenograft tolerance, suggesting a possible clinical strategy which may pave the way towards improving therapeutic outcomes of clinical islet transplantation.
Keyphrases
- dendritic cells
- regulatory t cells
- immune response
- randomized controlled trial
- transcranial direct current stimulation
- induced apoptosis
- drug delivery
- mesenchymal stem cells
- oxidative stress
- cell cycle arrest
- type diabetes
- combination therapy
- metabolic syndrome
- stem cells
- working memory
- adipose tissue
- mass spectrometry
- bone marrow
- insulin resistance
- weight loss
- smoking cessation
- drug induced
- drug release